awmsg logo



bromfenac (Yellox®)


Reference No. 1025

Publication date:
08/05/2014


Last review date:
08/05/2017

Appraisal information

bromfenac (Yellox®) 0.9 mg/ml eye drops


Company: Bausch & Lomb UK Ltd
BNF category: Eye
NMG meeting date: 22/01/2014
AWMSG meeting date: 19/02/2014
   
   
Submission Type: Full Submission
Status: Not recommended
Advice No: 0614
Ratification by Welsh Government: 07/05/2014

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

Bromfenac (Yellox®) is not recommended for use within NHS Wales for the treatment of postoperative ocular inflammation following cataract extraction in adults. The applicant company did not present a sufficiently robust comparative clinical analysis or economic analysis to gain approval by AWMSG. No economic analysis was submitted.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download